Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical ProgramArticle Published on 2023-01-052023-05-31 Journal: Inflammatory bowel diseases [Category] [DOI] 10.1093/ibd/izac084 PMC 바로가기
Long-term Risk of Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving TofacitinibClinical Trial Published on 2023-01-052023-05-31 Journal: Inflammatory bowel diseases [Category] [DOI] 10.1093/ibd/izac063 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control studyArticle Published on 2022-11-012022-11-15 Journal: The Lancet. Gastroenterology & Hepatology [Category] [DOI] 10.1016/S2468-1253(22)00274-6 PMC 바로가기
Patient preferences and current practice for adults with steroid-resistant ulcerative colitis: POPSTER mixed-methods studyArticle Published on 2022-10-012022-11-15 Journal: Health technology assessment (Winchester, England) [Category] [DOI] 10.3310/RHXR5192 PMC 바로가기
Identification of novel off targets of baricitinib and tofacitinib by machine learning with a focus on thrombosis and viral infection Research Published on 2022-05-122022-10-05 Journal: Scientific Reports [Category] [DOI] 10.1038/s41598-022-11879-1 [Article Type] Research
JAK inhibitors and COVID-19JAK 억제제 및 COVID-19Review Published on 2022-04-012022-09-11 Journal: Journal for immunotherapy of cancer [Category] [DOI] 10.1136/jitc-2021-002838 PMC 바로가기 [Article Type] Review
Pharmacological treatment of COVID-19: an opinion paperCOVID-19의 약리학적 치료: 의견서Review Published on 2022-04-012022-09-11 Journal: Revista española de quimioterapia : publicación [Category] [DOI] 10.37201/req/158.2021 PMC 바로가기 [Article Type] Review
Management of hepatitis B virus reactivation due to treatment of COVID-19코로나19 치료로 인한 B형 간염 바이러스 재활성화 관리Review Published on 2022-04-012022-09-11 Journal: Hepatology international [Category] [DOI] 10.1007/s12072-022-10306-x PMC 바로가기 [Article Type] Review
The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-AnalysisMedicine Published on 2022-01-272022-10-31 Journal: Frontiers in Medicine [Category] [DOI] 10.3389/fmed.2021.800492 PMC 바로가기 [Article Type] Medicine
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19COVID-19에서 면역조절 요법의 사용에 대해 고려해야 할 EULAR 포인트의 2021 업데이트Practice Guideline Published on 2022-01-012022-09-12 Journal: Annals of the rheumatic diseases [Category] [DOI] 10.1136/annrheumdis-2021-221366 PMC 바로가기 [Article Type] Practice Guideline